| Dr Arthur G Calise, DO | |
|
1 Bay Ave, Montclair, NJ 07042-4837 | |
| (973) 877-5000 | |
| Not Available |
| Full Name | Dr Arthur G Calise |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 32 Years |
| Location | 1 Bay Ave, Montclair, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184626509 | NPI | - | NPPES |
| 20349 | Other | NJ | UHP-NON PAR |
| 6863302 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 25MB06007700 (New Jersey) | Secondary |
| 207P00000X | Emergency Medicine | 25MB06007700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensackumc Mountainside | Montclair, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montclair Emergency Physicians Llc | 2264841857 | 18 |
News Archive
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
On the last of three days of arguments on the Affordable Care Act later this month, the U.S. Supreme Court will turn to the sleeper issue that could have the biggest impact on federal power - Congress' authority under its spending power to require a big expansion of state Medicaid programs.
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled trial in the March 24 online issue of the Journal of the National Cancer Institute.
Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.
› Verified 7 days ago
| Entity Name | Jfk Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396858874 PECOS PAC ID: 4385624162 Enrollment ID: O20040722000477 |
News Archive
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
On the last of three days of arguments on the Affordable Care Act later this month, the U.S. Supreme Court will turn to the sleeper issue that could have the biggest impact on federal power - Congress' authority under its spending power to require a big expansion of state Medicaid programs.
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled trial in the March 24 online issue of the Journal of the National Cancer Institute.
Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.
› Verified 7 days ago
| Entity Name | Emergency Physician Associates Of North Jersey P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497783419 PECOS PAC ID: 7911992326 Enrollment ID: O20040825001558 |
News Archive
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
On the last of three days of arguments on the Affordable Care Act later this month, the U.S. Supreme Court will turn to the sleeper issue that could have the biggest impact on federal power - Congress' authority under its spending power to require a big expansion of state Medicaid programs.
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled trial in the March 24 online issue of the Journal of the National Cancer Institute.
Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.
› Verified 7 days ago
| Entity Name | Intensivists At Highland Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528298817 PECOS PAC ID: 7113063249 Enrollment ID: O20091005000037 |
News Archive
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
On the last of three days of arguments on the Affordable Care Act later this month, the U.S. Supreme Court will turn to the sleeper issue that could have the biggest impact on federal power - Congress' authority under its spending power to require a big expansion of state Medicaid programs.
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled trial in the March 24 online issue of the Journal of the National Cancer Institute.
Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.
› Verified 7 days ago
| Entity Name | Emergency Associates Of Montclair Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598112146 PECOS PAC ID: 0244522241 Enrollment ID: O20160712002716 |
News Archive
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
On the last of three days of arguments on the Affordable Care Act later this month, the U.S. Supreme Court will turn to the sleeper issue that could have the biggest impact on federal power - Congress' authority under its spending power to require a big expansion of state Medicaid programs.
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled trial in the March 24 online issue of the Journal of the National Cancer Institute.
Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.
› Verified 7 days ago
| Entity Name | Montclair Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851979470 PECOS PAC ID: 2264841857 Enrollment ID: O20210512000447 |
News Archive
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
On the last of three days of arguments on the Affordable Care Act later this month, the U.S. Supreme Court will turn to the sleeper issue that could have the biggest impact on federal power - Congress' authority under its spending power to require a big expansion of state Medicaid programs.
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled trial in the March 24 online issue of the Journal of the National Cancer Institute.
Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arthur G Calise, DO 66 W Gilbert St, Suite 100, Tinton Falls, NJ 07701-4918 Ph: (721) 212-0060 | Dr Arthur G Calise, DO 1 Bay Ave, Montclair, NJ 07042-4837 Ph: (973) 877-5000 |
News Archive
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
On the last of three days of arguments on the Affordable Care Act later this month, the U.S. Supreme Court will turn to the sleeper issue that could have the biggest impact on federal power - Congress' authority under its spending power to require a big expansion of state Medicaid programs.
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled trial in the March 24 online issue of the Journal of the National Cancer Institute.
Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.
› Verified 7 days ago
Erik Sherman, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6000 | |
Dr. Augustine Yao Alifo, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6000 | |
Dr. Eric Fernandez, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6000 | |
Dr. Larry Carter, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6000 | |
Dr. Radha Kotamraju, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6991 | |
Dr. Mitchell Jerold Heller, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6000 | |
Viktor Livshits, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6000 |